Delia Alvarez

Delia Alvarez is an accomplished clinical operations professional with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as Executive Director of Clinical Operations at Inhibrx Biosciences, Inc. since May 2024, Delia has previously held multiple senior roles at Mirati Therapeutics, including Senior Director of Clinical Operations, Senior Director of Clinical Science, and Director of Clinical Science from May 2018 to May 2024. Earlier in the career, Delia contributed to TRACON Pharmaceuticals in various leadership positions, such as Director of Clinical Operations and Senior Clinical Trials Manager, spanning over a decade from August 2006 to May 2018. Additionally, Delia gained initial experience at Voices for Children as a Volunteer Training Coordinator. Delia Alvarez earned a Bachelor of Arts degree in Social Welfare from the University of California, Berkeley, between 1997 and 2001.